- Home
- Software Solutions
- Resources
- Corporate
Bevacizumab, Irinotecan and Temozolomide for Relapsed or Refractory Neuroblastoma
Sponsors:
| Phases:
| |
| Indications | Acronym: | |
| ||
Age Groups:
| Gender: Both | |
Names:
| Enrollment: 63 | |
Additional information about NCT01114555.